ISIC Q86 · China · 4 publishers
Healthcare in China
422 verified figures for China, covering 24 indicators from 4 primary sources. Every figure links to the report it came from.
China compared
| Measure | China | World | Highest country |
|---|---|---|---|
| Current health expenditure (CHE) as percentage of GDP (%) | 5.94%China · 2023 | — | 27.1%Tuvalu · 2023 |
| Current health expenditure (CHE) per capita (US$) | 763.4 USDChina · 2023 | — | 13,473.2 USDUnited States · 2023 |
| Domestic general government health expenditure as percentage of GDP (%) | 3.39%China · 2023 | — | 19.7%Tuvalu · 2023 |
| Oncology novel active substance (NAS) launches (cumulative) | 84China · 2020–2024 | 132World · 2020–2024 | 85United States · 2020–2024 |
The short version
Key takeaways
Market size and output 3
- Current health expenditure (CHE) per capita in China (US$) was 763.4 USD in 2023 (WHO). WHO ↗ T1 Official
- Current health expenditure (CHE) as percentage of GDP in China (%) was 5.94% in 2023 (WHO). WHO ↗ T1 Official
- Domestic general government health expenditure as percentage of GDP in China (%) was 3.39% in 2023 (WHO). WHO ↗ T1 Official
Adoption and share 3
- DTP3 immunization coverage among 1-year-olds in China (%) was 97% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds in China (%) was 95% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine second-dose (MCV2) immunization coverage in China (%) was 94% in 2025 (WHO). WHO ↗ T1 Official
Other measures 4
- Novel active substances launched exclusively in China were 30 in 2025 (IQVIA). IQVIA ↗
- Life expectancy at birth, total in China (years) was 78 years in 2024 (World Bank). World Bank ↗ T1 Official
- Adult obesity prevalence in China (age-standardized, %) was 9.29% in 2024 (WHO). WHO ↗ T1 Official
- Adult obesity prevalence: female in China (age-standardized, %) was 8.42% in 2024 (WHO). WHO ↗ T1 Official
The complete table
Healthcare data for China
Every row links to its own page with the full source, verbatim quote and citation.
422 data points across 24 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.
IndicatorPeriodValueSourceType
Adult obesity prevalence (age-standardized, %)+34 more20249.29%WHOT12024estimate→
Adult obesity prevalence: female (age-standardized, %)+34 more20248.42%WHOT12024estimate→
Adult obesity prevalence: male (age-standardized, %)+34 more20249.98%WHOT12024estimate→
Change in regional share of global clinical trial country uses2019–202357%IQVIA2023actual→
Current health expenditure (CHE) as percentage of GDP (%)+23 more20235.94%WHOT12023actual→
Current health expenditure (CHE) per capita (US$)+23 more2023763.4 USDWHOT12023actual→
Domestic general government health expenditure as percentage of GDP (%)+23 more20233.39%WHOT12023actual→
Domestic-only oncology NAS launches (cumulative)2020–202445IQVIA2024actual→
DTP3 immunization coverage among 1-year-olds (%)+25 more202597%WHOT12025estimate→
Health care and medical services price index growth rateAugust 20262.7%NBS ChinaT12026actual→
Life expectancy at birth, total (years)+64 more202478 yearsWorld BankT12024estimate→
Manufacture of medicines producer price index growth rate (monthly)August 2026-0.2%NBS ChinaT12026actual→
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)+25 more202595%WHOT12025estimate→
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)+25 more202594%WHOT12025estimate→
Medicine use index (2020=100)2020100 indexIQVIA2020actual→
NCD mortality rate (per 100,000 population)+21 more2021491.4 per 100,000 peopleWHOT12021estimate→
Novel active substances launched exclusively in China202530IQVIA2025actual→
Oncology novel active substance (NAS) launches (cumulative)+1 more2020–202484IQVIA2024actual→
Pharmaceutical manufacturing investment growth rateJanuary–July 2026-9.8%NBS ChinaT12026actual→
Premature NCD mortality probability (ages 30–70, %)+21 more202115.9%WHOT12021estimate→
Suicide mortality rate (per 100,000 population)+21 more20216.83 per 100,000 peopleWHOT12021estimate→
Tobacco use prevalence (ages 15+, age-standardized, %)+8 more202422.8%WHOT12024estimate→
Tobacco use prevalence: female (ages 15+, age-standardized, %)+8 more20241.5%WHOT12024estimate→
Tobacco use prevalence: male (ages 15+, age-standardized, %)+8 more202444.2%WHOT12024estimate→
Healthcare in China by topic
Primary documents
Sources
| Document | Publisher | Authority tier | Accessed | Locator | Data points |
|---|---|---|---|---|---|
| National Economy Remained Steady with Innovation-Led and High-Quality Development in August Press release | NBS China | T1 Official | 15 Sep 2026 | 7. Consumer Price Rose Mildly and Producer Prices for Industrial Products Grew Faster Year on Year. | 1 |
| Industrial Producer Price Indexes in August 2026 Press release | NBS China | T1 Official | 15 Sep 2026 | Table: Industrial Producer Price Indexes in August 2026 — III. Producer Price Indexes for Major Industries (Growth Rate M/M column) | 1 |
| Investment in Fixed Assets from January to July 2026 Press release | NBS China | T1 Official | 15 Sep 2026 | Table: Investment in Fixed Assets (Excluding Rural Households) from January to July 2026 | 1 |
| World Bank life expectancy at birth (total, years) Dataset | World Bank | T1 Official | 3 Oct 2026 | SP.DYN.LE00.IN: {"countryiso3code":"CHN","date":"2024","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"CHN","date":"2023","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"CHN","date":"2022","indicator.id":"SP.DYN.LE00.IN"} | 65 |
| WHO adult obesity prevalence (age-standardized, both sexes) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, female) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, male) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO current health expenditure (CHE) as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHEGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO current health expenditure (CHE) per capita in US$ Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHE_pc_US_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF DTP3 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS4_100: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS4_100: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS4_100: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO domestic general government health expenditure as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF MCV1 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS8_110: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS8_110: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS8_110: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO/UNICEF MCV2 immunization coverage by recommended age Dataset | WHO | T1 Official | 2 Oct 2026 | MCV2: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2025"}; MCV2: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; MCV2: {"SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO age-standardized NCD mortality rate (per 100,000 population, both sexes) Dataset | WHO | T1 Official | 3 Oct 2026 | WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2020"}; WHS2_131: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
| WHO probability of premature death from four main NCDs (ages 30–70, %) Dataset | WHO | T1 Official | 3 Oct 2026 | NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2020"}; NCDMORT3070: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
| WHO age-standardized suicide mortality rate (per 100,000 population, both sexes) Dataset | WHO | T1 Official | 3 Oct 2026 | MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2021"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2020"}; MH_12: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2019"} | 22 |
| WHO tobacco use prevalence (ages 15+, age-standardized, both sexes) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
| WHO tobacco use prevalence (ages 15+, age-standardized, female) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
| WHO tobacco use prevalence (ages 15+, age-standardized, male) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"CHN","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
| Rethinking Clinical Trial Country Prioritization Press release | IQVIA | T3 Research | 15 Sep 2026 | Key findings | 1 |
| Global Oncology Trends 2025 Press release | IQVIA | T3 Research | 16 Sep 2026 | Other Findings | 3 |
| Global Medicine Use Trends 2026 Press release | IQVIA | T3 Research | 15 Sep 2026 | Key Findings | 1 |
| Global R&D Trends 2026 Press release | IQVIA | T3 Research | 15 Sep 2026 | Key Findings | 1 |
Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.
All 422 collected records for China are published as verified.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. Each figure's own page carries APA, MLA, Chicago and BibTeX citations naming its original publisher.
StatOrigin. (2026). Healthcare in China: statistics. Retrieved from https://statorigin.org/industries/healthcare/china